MedAvail (NASDAQ:MDVL) and China Dasheng Biotechnology (OTCMKTS:CDBT) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, profitability and risk.
This is a breakdown of recent ratings for MedAvail and China Dasheng Biotechnology, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|China Dasheng Biotechnology||0||0||0||0||N/A|
Volatility & Risk
MedAvail has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, China Dasheng Biotechnology has a beta of 2.77, indicating that its stock price is 177% more volatile than the S&P 500.
This table compares MedAvail and China Dasheng Biotechnology’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|China Dasheng Biotechnology||N/A||N/A||N/A|
Valuation and Earnings
This table compares MedAvail and China Dasheng Biotechnology’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|MedAvail||$13.97 million||7.71||-$26.81 million||($3.80)||-0.87|
|China Dasheng Biotechnology||N/A||N/A||N/A||N/A||N/A|
China Dasheng Biotechnology has lower revenue, but higher earnings than MedAvail.
Insider & Institutional Ownership
86.8% of MedAvail shares are held by institutional investors. 3.7% of MedAvail shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
MedAvail beats China Dasheng Biotechnology on 5 of the 9 factors compared between the two stocks.
MedAvail Company Profile
MedAvail Holdings, Inc. is a technology-enabled pharmacy company. It provides turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. The firm helps patients to optimize drug adherence, resulting in better health outcomes. The company was founded on April 11, 2007 and is headquartered in Mississauga, Canada.
China Dasheng Biotechnology Company Profile
China Dasheng Biotechnology Co. engages in the development, manufacture and sale of bacteria based products, which are used as additives for livestock feed and crop cultivation. It operates through the following business segments: Agriculture Related Additives for Livestock Feed and Crop Cultivation. The company was founded on January 12, 2007 and is headquartered in Lanzhou, China.
Receive News & Ratings for MedAvail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedAvail and related companies with MarketBeat.com's FREE daily email newsletter.